21 results
·
21ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
MEDMIRA RAPID H. PYLORI ANTIBODY TEST, MODEL 10714
FDA 510(k)
FDA Class 1
·Microbiology
Duesseldorf Type Bell Partial
FDA UDI
Heinz Kurz GmbH·EHKM10020231·Ossicular prosthesis, partial
artVeneer life
FDA UDI
Merz Dental GmbH·D7092002023·artVeneer life lower posteriors, L, A3
nGenius
FDA UDI
Stryker Leibinger GmbH & Co. KG·07613327353600·SPINE CLAMP
CosmoLock Pedicle Screw System
FDA UDI
Kalitec Direct LLC·B07311K0120230·Screwdriver, Extended Tab, Fixed Tap Sleeve, As...
DULBECCO'S MODIFIED EAGLE'S MEDIUM, NO. 200-2023
FDA 510(k)
FDA Class 1
·Hematology
BREAST IMPLANT
FDA Adverse Event
DOW CORNING CORP.·Product code FTR·May 17, 1994
NITRILE PATIENT EXAMINATION GLOVES, POWDER-FREE
FDA 510(k)
FDA Class 1
·General Hospital
FRIENDLY LIGHT ER:YAG PULSED LASER
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
DEXTRUS 4136
FDA Adverse Event
Malfunction
·BIOTRONIK SE & CO. KG·Product code NVN·March 13, 2013
PUMP/GRAVITY SOLUTION NO 'Y' SITE
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE - MALTA·Product code FPA·February 27, 2011
ICY HOT HEAT THERAPY-BACK PATCH
FDA Adverse Event
Injury
·*·Product code IMD·February 20, 2008
ONYX
FDA Adverse Event
Injury
·MICRO THERAPEUTICS, INC. DBA EV3·Product code MFE·October 16, 2024
Verigene Enteric Pathogens Nucleic Acid Test (EP), REF 30-002-023
FDA Recall
Open, Classified
·Luminex Corporation·Product code PCH·June 5, 2023
CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System, 120 channels, using firmware version 2.08. The channel numbers in the amplifier are as follows: Material number: H30120020210 - 40 Channel CLEARSIGN II Amplifier, catalog number 2002021; Material number: H30120020220 80 Channel CLEARSIGN II Amplifier, catalog number 2002022; Material number: H30120020230 120 Channel CLEARSIGN II Amplifier, catalog number 2002023; Material number: H30120020240 160 Channel Clearsign II Amplifier, catalog number 2002014. The CLEARSIGN II Amplifier is intended to amplify and condition electrocardiographic signals of biologic origin and pressure transducer input, transmitting this information to a host computer (the LABSYSTEM PRO EP Recording System) that can record and display the information
FDA Enforcement
Class II
·Terminated·Boston Scientific Corporation·June 24, 2015
HAMILTON MEDICAL AG
FDA Adverse Event
Malfunction
·HAMILTON MEDICAL AG·Product code CBK·December 21, 2023
Verigene Enteric Pathogens Nucleic Acid Test (EP), REF 30-002-023
FDA Enforcement
Class II
·Ongoing·Luminex Corporation·July 5, 2023
CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System, 120 channels, using firmware version 2.08. The channel numbers in the amplifier are as follows: Material number: H30120020210 - 40 Channel CLEARSIGN II Amplifier, catalog number 2002021; Material number: H30120020220 80 Channel CLEARSIGN II Amplifier, catalog number 2002022; Material number: H30120020230 120 Channel CLEARSIGN II Amplifier, catalog number 2002023; Material number: H30120020240 160 Channel Clearsign II Amplifier, catalog number 2002014. The CLEARSIGN II Amplifier is intended to amplify and condition electrocardiographic signals of biologic origin and pressure transducer input, transmitting this information to a host computer (the LABSYSTEM PRO EP Recording System) that can record and display the information
FDA Recall
Terminated
·Boston Scientific Corporation·Product code DRQ·June 2, 2015
1202 Flex Focus Ultrasound System, cart models UA1214 and UA1814, used with: Flex Focus 200, Flex Focus 300, Flex Focus 400, Flex Focus 500, Flex Focus 700, Flex Focus 800; System, Imaging, Pulsed Doppler, Ultrasonic
FDA Enforcement
Class II
·Ongoing·B-K Medical A/S·November 12, 2025
CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.
FDA Enforcement
Class I
·Ongoing·Smiths Medical ASD Inc.·August 14, 2024